Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate GH Research PLC before investing.

In this article, we go over a few key elements for understanding GH Research PLC’s stock price such as:

• GH Research PLC’s current stock price and volume
• Why GH Research PLC’s stock price changed recently
• Upgrades and downgrades for GHRS from analysts
• GHRS’s stock price momentum as measured by its relative strength

About GH Research PLC (GHRS)

Before we jump into GH Research PLC’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an inhalable mebufotenin product candidate, which is in phase 2b clinical trial for treating patients with treatment-resistant depression; and in phase 2a clinical trial for treating bipolar II disorder and a current major depressive episode, as well as female patients with postpartum depression. The company also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

Want to learn more about GH Research PLC’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about GH Research PLC.

GH Research PLC’s Stock Price as of Market Close

As of December 11, 2025, 3:59 PM, CST, GH Research PLC’s stock price was $13.840.

GH Research PLC is down 2.6% from its previous closing price of $14.210.

During the last market session, GH Research PLC’s stock traded between $13.705 and $15.000. Currently, there are approximately 62.03 million shares outstanding for GH Research PLC.

GH Research PLC’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

GH Research PLC Stock Price History

GH Research PLC’s (GHRS) price is currently down 8.71% so far this month.

During the month of December, GH Research PLC’s stock price has reached a high of $15.860 and a low of $13.705.

Over the last year, GH Research PLC has hit prices as high as $20.500 and as low as $6.720. Year to date, GH Research PLC’s stock is up 97.71%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused GH Research PLC Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 10, 2025, there was 1 analyst who downgraded GH Research PLC’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate GH Research PLC’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on GH Research PLC’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about GH Research PLC (GHRS) by visiting AAII Stock Evaluator.

Relative Price Strength of GH Research PLC

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 10, 2025, GH Research PLC has a weighted four-quarter relative price strength of 12.09%, which translates to a Momentum Score of 84 and is considered to be Very Strong.

Want to learn more about how GH Research PLC is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

GH Research PLC Stock Price: Bottom Line

As of December 11, 2025, GH Research PLC’s stock price is $13.840, which is down 2.6% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like GH Research PLC stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.